Nutriband inc. expands product development pipeline for its aversa(tm) platform abuse deterrent technology

Orlando, fl / accesswire / january 18, 2022 / nutriband inc. (nasdaq:ntrb)(nasdaq:ntrbw) announced an expanded product development pipeline for its proprietary aversa™ abuse deterrent transdermal technology. the aversa abuse deterrent technology platform can be applied to any transdermal patch that has a risk of abuse, misuse or accidental exposure.

NTRB Ratings Summary

NTRB Quant Ranking